title: Hope for a rare disease: eculizumab in neuromyelitis optica.
authors.affiliation: NeuroCure Clinical Research Center and Department of Neurology, Clinical and Experimental Multiple Sclerosis Research Center, Charité University Medicine Berlin, Berlin, Germany. friedemann.paul@charite.de
authors.forename: Friedemann
authors.initials: F
authors.lastname: Paul
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D051401:Aquaporin 4 / Q000276:immunology*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000096:biosynthesis*; D008297:Male; D009471:Neuromyelitis Optica / Q000097:blood* / Q000188:drug therapy*
chemical_list: C496030:AQP4 protein, human; D061067:Antibodies, Monoclonal, Humanized; D051401:Aquaporin 4; D007074:Immunoglobulin G; C481642:eculizumab